Subgroup Analysis of Patients With and Without Serum Anti-p53 Antibody (p53-Ab)
death
Nelson-Aalen cumulative hazard curves for relapse or death in p53-Ab (+) and p53-Ab (−) groups, assessing patients taking vitamin D vs those taking placebo, were compared using hazard ratios and 95% CIs.